Literature DB >> 16421801

Routine childhood bacille Calmette Guérin immunization and HIV infection.

C Fordham von Reyn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16421801     DOI: 10.1086/499959

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  6 in total

1.  Reduced rate of adverse reactions to the BCG vaccine in children exposed to the vertical transmission of HIV infection and in HIV-infected children from an endemic setting in Brazil.

Authors:  Regina Célia de Souza Campos Fernandes; Luciana Cordeiro de Araújo; Enrique Medina-Acosta
Journal:  Eur J Pediatr       Date:  2008-09-03       Impact factor: 3.183

2.  Challenges of Childhood TB/HIV Management in Malawi.

Authors:  G Poerksen; Pn Kazembe; Sm Graham
Journal:  Malawi Med J       Date:  2007-12       Impact factor: 0.875

Review 3.  BCG: a vaccine with multiple faces.

Authors:  Marco Antonio Yamazaki-Nakashimada; Alberto Unzueta; Luisa Berenise Gámez-González; Napoleón González-Saldaña; Ricardo U Sorensen
Journal:  Hum Vaccin Immunother       Date:  2020-01-29       Impact factor: 3.452

4.  Comparative tuberculosis (TB) prevention effectiveness in children of Bacillus Calmette-Guérin (BCG) vaccines from different sources, Kazakhstan.

Authors:  Michael Favorov; Mohammad Ali; Aigul Tursunbayeva; Indira Aitmagambetova; Paul Kilgore; Shakhimurat Ismailov; Terence Chorba
Journal:  PLoS One       Date:  2012-03-09       Impact factor: 3.240

5.  Malaria infections do not compromise vaccine-induced immunity against tuberculosis in mice.

Authors:  Marcela Parra; Steven C Derrick; Amy Yang; Jinhua Tian; Kristopher Kolibab; Miranda Oakley; Liyanage P Perera; William R Jacobs; Sanjai Kumar; Sheldon L Morris
Journal:  PLoS One       Date:  2011-12-19       Impact factor: 3.240

Review 6.  Macaque models of human infectious disease.

Authors:  Murray B Gardner; Paul A Luciw
Journal:  ILAR J       Date:  2008
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.